CompoAtlas

Lightening Lotion

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut Quelle
1,4-Benzènediol

Quelle : Hydroquinone

2 %

Nicht arzneiliche Inhaltsstoffe

Lentinus Edodes Mycelium Extract, Caprylyl glycol, EDTA de sodium, Stéarate de tridécyle, xylitol, Ethylhexylglycérine, Eau, Glucoside de cétéaryle, Tridecyl trimellitate, Métabisulfite de sodium, Glycérine, Sulfite de sodium, Extrait de racine de Glycyrrhiza Glabra (Réglisse), Triméthylpentanediaol/Copolymère d'acide adipique, Polyglyceryl-6 Palmitate/Succinate, Anhydroxylitol, Butylène glycol, Diméthicone, Acide octanoïque, Gomme de xanthane, Stéarate de glycéryle, Dicaprylate/dicaprate de néopentyl glycol, Lévulinate de sodium, NA, Acide citrique, Benzoate de Sodium, Alcool béhénylique, Hydroxyde de sodium, Interpolymère de Carbomère, Stéarate de sorbitan, Lécithine hydrogénée, Tocophérol, Alcool cétéarylique, Sesquicaprylate de xylityle, Propanediol

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
AdultesNon précisée1 Lotion2 Tous les jours

In Kanada zugelassene Verwendungen

For the gradual fading/lightening of dark (browning) discoloration in the skin such as freckles, age and liver spots, pigment in the skin that may occur during pregnancy (for use only after childbirth and only if not breastfeeding) or from the use of oral contraceptives. Skin bleaching (agent).

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Cautions and Warnings : To be used only on the advice of a physician. The physician should be familiar with the information on this label (in this insert) before prescribing or dispensing this product. Close patient supervision is recommended. Use only as directed. For external use only. Do not apply over sunburn, irritated or broken skin. Avoid contact with eyes or mucous membranes (In case of contact, rinse thoroughly with water). A mild transient stinging or minor redness may occur in people with sensitive skin. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. Apply only to small skin surface areas and limit treatment to relatively small skin surface areas of the body at one time. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Sun exposure should limited by applying (using) a sunscreen SPF 15 or higher or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring. In case of accidental ingestion, seek medical assistance or contact Poison Control Center immediately. A bitter taste and anesthetic effect may occur if applied to lips. Test for sensitivity. To test for sensitivity, apply to an area of approximately 1 cm of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Wash your hand thoroughly after applying hydroquinone unless your hands are the treated area. Keep out of the reach of children. Note: Slight darkening of the product is normal when exposed to air and does not affect potency. (When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If entire content becomes brown, discontinue use and consult a physician.

Originaltext auf Englisch.

Contra-Indications : People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use this product. If you have a family history of, have or have had, or are at risk of developing skin cancer, do not use. The safety of topical hydroquinone use during pregnancy, lactation or for children under 12 years old has not been established. Not for use on children under 12 years of age unless directed by a physician (doctor). Do not use this product if you are breastfeeding or pregnant, or if you intend to become pregnant within three months of use. Do not use this product with other products that contain hydrogen peroxide or benzoyl peroxide (may cause a dark staining of your skin that can be removed by discontinuing peroxide use and washing skin with soap and water).

Originaltext auf Englisch.

Known Adverse Reactions : Some users of this product may experience a mild skin irritation. Minor redness is acceptable but if skin irritation, itching or reddening becomes severe, or in case of rash, excessive inflammatory response, or if a gradual blue-black darkening of the skin occurs, stop (discontinue) use and consult a physician (doctor). Contains sodium metabisulfite, a sulfite that may cause serious allergic type reactions (e.g. hives, itching, wheezing, anaphylaxis, severe asthma attacks) in certain susceptible persons.

Originaltext auf Englisch.

Produktdaten

Andere Namen
Alumier Lightening Lotion, Alumier Lightening Lotion 2%, Alumier MD Lightening Lotion, Alumier MD Lightening Lotion 2%, Alumier MD Pigment Fading Lotion, Alumier Pigment Fading Lotion, Lightening Lotion 2%, Pigment Fading Lotion
Inhaber
Alumier Europe Ltd.
NPN oder DIN-HM
80062530
Status
Aktive Lizenz
Lizenzdatum
7. Juli 2015
Überarbeitungsdatum
11. September 2026
Form
Lotion
Verabreichungsweg
Topique
Art des Antrags
Non traditionnelle

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80062530

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile